# Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

> **NCT00053872** · PHASE3 · UNKNOWN · sponsor: **University of Leicester** · enrollment: 316 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** cisplatin
- **DRUG:** lomustine
- **DRUG:** vincristine sulfate
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00053872
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053872, "Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00053872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*